Free Trial
OTCMKTS:CNTTF

CannTrust (CNTTF) Stock Price, News & Analysis

CannTrust logo

About CannTrust Stock (OTCMKTS:CNTTF)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
1.43 million shs
Average Volume
528,025 shs
Market Capitalization
$1.01 billion
P/E Ratio
137.18
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CNTTF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CannTrust and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CNTTF Stock News Headlines

CannTrust Holdings Inc CNTTQ
The roadshow starts Monday. This stock isn't ready.
The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the world's largest fund managers - including a section naming one small company Musk's Colossus cannot operate without. Right now, most fund managers have never heard of it. By Friday, every one of them will. Dylan Jovine has identified the name and ticker before $75 billion in new capital starts chasing the SpaceX supply chain.tc pixel
Annexon (NASDAQ: ANNX)
Nektar Therapeutics (NASDAQ: NKTR)
OptiNose (NASDAQ: OPTN)
Cybin (NYSEMKT: CYBN)
See More Headlines

CNTTF Stock Analysis - Frequently Asked Questions

Shares of CNTTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:CNTTF
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
137.18
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$15.96 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
105,608,000
Free Float
N/A
Market Cap
$1.01 billion
Optionable
Not Optionable
Beta
4.52
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.

Get This Free Report

This page (OTCMKTS:CNTTF) was last updated on 6/10/2026 by MarketBeat.com Staff.
From Our Partners